alli 60 mg orlistat weight-loss aid
alli is an over-the-counter orlistat 60 mg weight-loss aid for adults, used with a reduced-calorie, low-fat diet. MyAlli provides the official product information and…
alli is an over-the-counter orlistat 60 mg weight-loss aid for adults, used with a reduced-calorie, low-fat diet. MyAlli provides the official product information and…
Omada Health is a virtual, benefit-based health program. Its Prevention & Weight Health service combines a health coach, weekly learning, tracking tools and, for…
Parsley Health provides functional and reproductive-health care, including clinician visits, diagnostic testing and nutrition coaching. Its fertility-related support sits within a broader membership and…
Reverse Health is a subscription wellness app for women over 40, with meal plans, recipes, exercise videos and progress tools. Its terms say the…
Winona is a menopause-focused telehealth service offering prescription hormone therapy and non-hormonal options. It is not a weight-loss clinic and does not prescribe GLP-1…
Noom Med combines clinician-reviewed weight-care pathways with Noom’s behavior-change app, lessons and coaching. Its public pricing includes bundled self-pay plans and branded-prescription support; exact…
Hims Weight Loss charges $39 for the first membership month, then $149/month, with medication billed separately. Its current public pages list FDA-approved Wegovy options…
Once-daily oral GLP-1 pill from Eli Lilly, FDA-approved April 1, 2026 for weight management in adults. Launch self-pay price from $149/month for the lowest…
Once-weekly tirzepatide injection from Eli Lilly, FDA-approved for type 2 diabetes. Not approved for weight management. Official self-pay price not publicly verified (Sept 20,…
Once-weekly tirzepatide injection from Eli Lilly, FDA-approved for chronic weight management and obstructive sleep apnea in adults with obesity. Self-pay $299 to $449/month via…
Once-weekly semaglutide injection from Novo Nordisk, FDA-approved for type 2 diabetes and related heart and kidney risk reduction. Not approved for weight management. Self-pay…
Once-daily oral semaglutide tablet from Novo Nordisk, FDA-approved December 2025 for weight management and cardiovascular risk reduction in adults. Self-pay $149 to $299/month by…